Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroglia | 7 | 2026 | 224 | 2.830 |
Why?
|
| C9orf72 Protein | 6 | 2019 | 33 | 2.530 |
Why?
|
| Lipid Droplets | 4 | 2025 | 51 | 2.000 |
Why?
|
| DNA Repeat Expansion | 6 | 2019 | 31 | 1.610 |
Why?
|
| Frontotemporal Dementia | 5 | 2019 | 56 | 1.540 |
Why?
|
| Amyotrophic Lateral Sclerosis | 5 | 2019 | 161 | 1.410 |
Why?
|
| Alzheimer Disease | 6 | 2025 | 878 | 1.370 |
Why?
|
| Neurons | 10 | 2025 | 1979 | 0.990 |
Why?
|
| tau Proteins | 2 | 2025 | 257 | 0.880 |
Why?
|
| Lipid Metabolism | 2 | 2024 | 387 | 0.830 |
Why?
|
| Sleep | 2 | 2024 | 381 | 0.810 |
Why?
|
| Drosophila Proteins | 4 | 2026 | 718 | 0.800 |
Why?
|
| Oxidative Stress | 2 | 2024 | 791 | 0.730 |
Why?
|
| beta Karyopherins | 1 | 2021 | 15 | 0.690 |
Why?
|
| ran GTP-Binding Protein | 1 | 2021 | 25 | 0.690 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2021 | 31 | 0.680 |
Why?
|
| Karyopherins | 1 | 2021 | 35 | 0.680 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2021 | 67 | 0.660 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2323 | 0.640 |
Why?
|
| Dipeptides | 3 | 2019 | 60 | 0.640 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2019 | 36 | 0.590 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 330 | 0.570 |
Why?
|
| Drosophila melanogaster | 5 | 2026 | 789 | 0.560 |
Why?
|
| Drosophila | 8 | 2025 | 739 | 0.540 |
Why?
|
| Parkinson Disease | 1 | 2024 | 735 | 0.500 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 521 | 0.480 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 781 | 0.470 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1363 | 0.450 |
Why?
|
| Nuclear Proteins | 3 | 2019 | 1211 | 0.420 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1089 | 0.410 |
Why?
|
| Transcription Factors | 3 | 2019 | 2406 | 0.410 |
Why?
|
| Animals | 18 | 2026 | 33912 | 0.360 |
Why?
|
| Amyloid beta-Peptides | 2 | 2025 | 229 | 0.350 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4697 | 0.280 |
Why?
|
| Brain | 4 | 2026 | 3175 | 0.270 |
Why?
|
| RNA | 2 | 2019 | 517 | 0.240 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2026 | 81 | 0.230 |
Why?
|
| Clusterin | 1 | 2025 | 11 | 0.220 |
Why?
|
| Glutamic Acid | 1 | 2026 | 200 | 0.220 |
Why?
|
| Astrocytes | 2 | 2025 | 264 | 0.220 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2026 | 160 | 0.220 |
Why?
|
| Serine Endopeptidases | 1 | 2026 | 197 | 0.220 |
Why?
|
| Cell Communication | 1 | 2025 | 188 | 0.210 |
Why?
|
| Actins | 1 | 2026 | 321 | 0.210 |
Why?
|
| Glucosylceramidase | 1 | 2024 | 33 | 0.210 |
Why?
|
| Coculture Techniques | 1 | 2024 | 230 | 0.200 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 664 | 0.200 |
Why?
|
| Glycoproteins | 1 | 2026 | 346 | 0.200 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 533 | 0.190 |
Why?
|
| Exocytosis | 1 | 2023 | 65 | 0.190 |
Why?
|
| Humans | 19 | 2026 | 131163 | 0.190 |
Why?
|
| Alleles | 3 | 2025 | 1673 | 0.180 |
Why?
|
| Peptide Fragments | 1 | 2025 | 687 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 2 | 2026 | 1075 | 0.170 |
Why?
|
| Sleep Wake Disorders | 1 | 2024 | 204 | 0.170 |
Why?
|
| Lysosomes | 1 | 2023 | 268 | 0.160 |
Why?
|
| Cells, Cultured | 2 | 2024 | 2885 | 0.160 |
Why?
|
| Seizures | 1 | 2026 | 890 | 0.160 |
Why?
|
| Mitochondria | 1 | 2026 | 785 | 0.160 |
Why?
|
| Animals, Genetically Modified | 2 | 2019 | 291 | 0.160 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 623 | 0.160 |
Why?
|
| GC Rich Sequence | 1 | 2019 | 6 | 0.160 |
Why?
|
| Sequence Alignment | 1 | 2021 | 582 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 280 | 0.150 |
Why?
|
| Gene Dosage | 1 | 2021 | 435 | 0.150 |
Why?
|
| RNA Polymerase II | 1 | 2019 | 83 | 0.150 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 204 | 0.150 |
Why?
|
| Protein Biosynthesis | 2 | 2019 | 569 | 0.150 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 362 | 0.150 |
Why?
|
| Epilepsy | 1 | 2026 | 876 | 0.140 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2018 | 13 | 0.140 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 34 | 0.140 |
Why?
|
| Rats | 1 | 2024 | 3370 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2026 | 3436 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 1011 | 0.130 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2395 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2018 | 161 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2026 | 4686 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 950 | 0.120 |
Why?
|
| Peptides | 1 | 2019 | 708 | 0.120 |
Why?
|
| Mice | 6 | 2025 | 18301 | 0.110 |
Why?
|
| Genome, Human | 1 | 2021 | 1321 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 109 | 0.100 |
Why?
|
| Myotonic Dystrophy | 1 | 2014 | 73 | 0.100 |
Why?
|
| Glioma | 1 | 2018 | 494 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 821 | 0.100 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 61 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2016 | 760 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2013 | 440 | 0.080 |
Why?
|
| Proteins | 1 | 2016 | 1006 | 0.080 |
Why?
|
| Male | 6 | 2026 | 64957 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2013 | 371 | 0.070 |
Why?
|
| Female | 6 | 2021 | 70963 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8635 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 6099 | 0.070 |
Why?
|
| Dynamins | 1 | 2026 | 51 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 378 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2025 | 1833 | 0.060 |
Why?
|
| Mitochondrial Dynamics | 1 | 2026 | 56 | 0.060 |
Why?
|
| Infant | 1 | 2021 | 13352 | 0.060 |
Why?
|
| Tauopathies | 1 | 2025 | 72 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2025 | 269 | 0.050 |
Why?
|
| Transcriptome | 2 | 2025 | 1103 | 0.050 |
Why?
|
| Lipid Peroxides | 1 | 2023 | 15 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2023 | 21 | 0.050 |
Why?
|
| R-SNARE Proteins | 1 | 2023 | 21 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2023 | 93 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2025 | 238 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 1939 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 157 | 0.040 |
Why?
|
| Iron | 1 | 2023 | 304 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2326 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2019 | 131 | 0.030 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2018 | 22 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 102 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 274 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 645 | 0.030 |
Why?
|
| Eye | 1 | 2018 | 215 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 825 | 0.030 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2016 | 28 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2833 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2014 | 71 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 251 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2016 | 254 | 0.030 |
Why?
|
| RNA Stability | 1 | 2014 | 77 | 0.030 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 64 | 0.020 |
Why?
|
| Stem Cells | 1 | 2018 | 702 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2019 | 2550 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2014 | 307 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 414 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2014 | 556 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 639 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 819 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 3748 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1481 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5063 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 757 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2013 | 1077 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1801 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1928 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 2026 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 4497 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 4886 | 0.010 |
Why?
|